Landfar Bio-medicine Co., Ltd (000504.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.87B
Enterprise Value2.85B
P/E Ratio64.07
PEG Ratio0.03
Price/Sales Ratio5.3
Price/Book Ratio9.83
Enterprise/Revenue5.6
Enterprise/EBITDA67.31

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.08
Operating Margin0.07
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.17

Income Statement

Revenue415.94M
Revenue/Share1.55
Gross Profit91.8M
EBITDA29.14M
Net Income28.83M
Diluted EPS0.09

Balance Sheet

Total Cash303.37M
Total Cash/Share0.92
Total Debt336.58M
Total Debt/Equity1.22
Current Ratio1.38
Book Value Per Share1.12

Price History

52-Week Change-6.47
52-Week High12.54
52-Week Low7.46
Moving Average 50 Days9.23
Moving Average 200 Days9.26

Statistics

Average Volume4.19M
Shares Outstanding330.02M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.03
Last Split Factor13:10
Last Split DateJanuary 15, 2007
AD